HomeMCRB • NASDAQ
add
Seres Therapeutics Inc
Previous close
$7.48
Day range
$7.18 - $8.57
Year range
$7.18 - $30.60
Market cap
1.42B USD
Avg Volume
60.93K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 23.71M | -30.29% |
Net income | -15.64M | 62.09% |
Net profit margin | — | — |
Earnings per share | -2.20 | 60.23% |
EBITDA | -27.75M | 21.59% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 30.79M | -75.94% |
Total assets | 139.81M | -61.01% |
Total liabilities | 126.03M | -68.76% |
Total equity | 13.78M | — |
Shares outstanding | 174.36M | — |
Price to book | 93.52 | — |
Return on assets | -45.26% | — |
Return on capital | -64.67% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -15.64M | 62.09% |
Cash from operations | -38.88M | 18.14% |
Cash from investing | -90.00K | 89.74% |
Cash from financing | 1.74M | -72.98% |
Net change in cash | -37.24M | 11.23% |
Free cash flow | -29.78M | -424.59% |
About
CEO
Founded
2010
Website
Employees
103
